ESSA Pharma Inc
NASDAQ:EPIX
ESSA Pharma Inc
Total Receivables
ESSA Pharma Inc
Total Receivables Peer Comparison
Competitive Total Receivables Analysis
Latest Figures & CAGR of Competitors
Company | Total Receivables | CAGR 3Y | CAGR 5Y | CAGR 10Y | |
---|---|---|---|---|---|
ESSA Pharma Inc
NASDAQ:EPIX
|
Total Receivables
$180.6k
|
CAGR 3-Years
-3%
|
CAGR 5-Years
-2%
|
CAGR 10-Years
N/A
|
|
Zymeworks Inc
NYSE:ZYME
|
Total Receivables
$19.5m
|
CAGR 3-Years
8%
|
CAGR 5-Years
118%
|
CAGR 10-Years
N/A
|
|
Repare Therapeutics Inc
NASDAQ:RPTX
|
Total Receivables
$15.3m
|
CAGR 3-Years
35%
|
CAGR 5-Years
69%
|
CAGR 10-Years
N/A
|
|
Fusion Pharmaceuticals Inc
NASDAQ:FUSN
|
Total Receivables
$5.5m
|
CAGR 3-Years
90%
|
CAGR 5-Years
61%
|
CAGR 10-Years
N/A
|
|
Aurinia Pharmaceuticals Inc
NASDAQ:AUPH
|
Total Receivables
$28.9m
|
CAGR 3-Years
189%
|
CAGR 5-Years
135%
|
CAGR 10-Years
76%
|
|
Spectral Medical Inc
TSX:EDT
|
Total Receivables
CA$186k
|
CAGR 3-Years
-11%
|
CAGR 5-Years
-35%
|
CAGR 10-Years
-11%
|
See Also
What is ESSA Pharma Inc's Total Receivables?
Total Receivables
180.6k
USD
Based on the financial report for Dec 31, 2023, ESSA Pharma Inc's Total Receivables amounts to 180.6k USD.
What is ESSA Pharma Inc's Total Receivables growth rate?
Total Receivables CAGR 5Y
-2%
The average annual Total Receivables growth rates for ESSA Pharma Inc have been -3% over the past three years , -2% over the past five years .